
Sign up to save your podcasts
Or


We discuss the use of the newly approved Susvimo system for sustained delivery of ranibizumab in the treatment of neovascular AMD with Carl Regillo, MD, Professor of Ophthalmology Thomas Jefferson University and Director of the Retina Service at the Wills Eye Hospital.
By Retina Synthesis4.5
88 ratings
We discuss the use of the newly approved Susvimo system for sustained delivery of ranibizumab in the treatment of neovascular AMD with Carl Regillo, MD, Professor of Ophthalmology Thomas Jefferson University and Director of the Retina Service at the Wills Eye Hospital.

43 Listeners

18 Listeners

100 Listeners

111,948 Listeners

56,508 Listeners

5 Listeners

9,532 Listeners

11 Listeners

47,654 Listeners

50 Listeners

11 Listeners

466 Listeners

19 Listeners

0 Listeners